Mackenzie Financial
CNMD icon

Mackenzie Financial’s CONMED CNMD Stock Holding History

Mackenzie Financial’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,753
Closed -$235K – 1491
2023
Q2 		$235K Buy
+1,753
New +$214K ﹤0.01% 1271
2022
Q2 		– Sell
-1,645
Closed -$244K – 1472
2022
Q1 		$244K Buy
1,645
+73
+5% +$10.2K ﹤0.01% 1213
2021
Q4 		$223K Sell
1,572
-132
-8% -$18.7K ﹤0.01% 1287
2021
Q3 		$223K Buy
+1,704
New +$223K ﹤0.01% 1267
2016
Q4 		– Sell
-9,713
Closed -$389K – 655
2016
Q3 		$389K Hold
9,713
– – ﹤0.01% 529
2016
Q2 		$464K Hold
9,713
– – ﹤0.01% 769
2016
Q1 		$407K Hold
9,713
– – ﹤0.01% 690
2015
Q4 		$428K Buy
+9,713
New +$422K ﹤0.01% 698

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Mackenzie Financial's CNMD Position: Q3 2023 in Review

Mackenzie Financial sold out of CONMED (CNMD) in Q3 2023, closing a stake of 1,753 shares — an estimated $235K sold.

Mackenzie Financial first reported a position in CNMD in Q4 2015 and held it in 8 quarters. The position peaked at $464K in Q2 2016. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

  • Mackenzie Financial reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
  • Mackenzie Financial sold 1,753 CONMED shares in Q3 2023, an estimated $235K.
  • Mackenzie Financial first reported a position in CONMED in Q4 2015 and held it in 8 quarters.
  • Mackenzie Financial's CONMED position peaked at $464K in Q2 2016.
  • 275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.